Generally the available therapeutic evidence for acute urticaria is quantitatively and qualitatively weak. RCTs of the therapeutic efficacy of the second-generation antihistamines are lacking, although one would like to consider these the first choice of therapy based on the studies in chronic urticaria.3 There is some evidence that the combination of H1 and H2 antagonists has additional beneficial effects. A short-term intervention with corticosteroids seems to be superior to a treatment with antihistamines alone, but should be considered in the context of individual needs.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.